Chs Inc
CHSCP Nasdaq Wholesale-Farm Product Raw Materials Financials FY2016βFY2025
What Chs Inc does
No business description yet.
- Legal name
- CHS INC
- Fiscal year ends
- August 31, 2025
- Latest annual report
- 10-K Β· Nov 5, 2025
- Accession Β· CIK
- 0000823277-25-000038
0000823277
Revenue and margins
Chs Inc had $35.5B of revenue in fiscal 2025, down 9.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$92.8M in fiscal 2025, β0.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Chs Inc returned β to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Chs Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $413M | $794M | $1.8B | $1.3B | $328M |
| Debt incl. finance leases | $1.6B | $1.7B | $1.9B | $2.2B | $1.8B |
| Net debt / EBITDA | 1.7x | 0.6x | 0.1x | 0.8x | 2.0x |
| Debt / equity | 0.2x | 0.2x | 0.2x | 0.2x | 0.2x |
| Interest coverage | 2.0x | 9.9x | 9.8x | 5.6x | 0.6x |
| Current ratio | 1.3x | 1.3x | 1.5x | 1.6x | 1.5x |
| Quick ratio | 0.7x | 0.8x | 1.0x | 1.0x | 0.9x |
| Total assets | $17.6B | $18.8B | $19.0B | $18.7B | $18.9B |
| Total liabilities | $8.6B | $9.4B | $8.5B | $8.0B | $7.8B |
| Shareholders' equity | $9.0B | $9.5B | $10.4B | $10.8B | $11.1B |
| Net debt (β = net cash) | $1.2B | $919M | $104M | $870M | $1.5B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 8 | 7 / 8 | 7 / 8 | 4 / 8 | 6 / 8 | 8 / 8 | 6 / 8 | 4 / 8 | 4 / 8 |
| Accruals ratio | β5.1% | β5.3% | β1.9% | β1.9% | β4.1% | β1.2% | β1.5% | β7.3% | β0.9% | β0.2% |
| Altman Z'' | 1.44 | 1.24 | 1.83 | 2.17 | 2.29 | 2.13 | 2.66 | 3.32 | 3.28 | 3.02 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $30.4B | $32.0B | $32.7B | $31.9B | $28.4B | $38.4B | $47.8B | $45.6B | $39.3B | $35.5B |
| Net interest income | β$75.3M | β | β | β | β | β | β | β | β | β |
| Gross profit | $969M | $894M | $1.1B | $1.4B | $982M | $951M | $2.1B | $2.4B | $1.8B | $1.1B |
| Operating income | $292M | β$174M | $452M | $660M | $277M | $206M | $1.1B | $1.3B | $584M | $90.8M |
| Interest expense | $114M | $171M | $149M | $167M | $117M | $105M | $114M | $137M | $104M | $146M |
| Pretax income | $402M | β$110M | $671M | $816M | $387M | $515M | $1.8B | $2.0B | $1.1B | $615M |
| Income tax | $19.1M | β$181M | β$104M | β$12.5M | β$36.7M | β$38.2M | $132M | $108M | β$4.9M | $16.8M |
| Net income | $383M | $71.6M | $776M | $830M | $422M | $554M | $1.7B | $1.9B | $1.1B | $598M |
| Cash flow | ||||||||||
| Cash from operations | $1.3B | $955M | $1.1B | $1.1B | $1.1B | $758M | $1.9B | $3.3B | $1.3B | $636M |
| Capital expenditure | $693M | $444M | $355M | $443M | $418M | $318M | $354M | $565M | $809M | $729M |
| Free cash flow | $568M | $510M | $719M | $697M | $669M | $440M | $1.6B | $2.7B | $464M | β$92.8M |
| Depreciation and amortization | $447M | $480M | $478M | $473M | $477M | $462M | $462M | $540M | $570M | $651M |
| Acquisitions | $11.9M | $0.0M | $0.0M | $119M | β$0.2M | $0.0M | β | $0.0M | $0.0M | $237M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $290M | $181M | $451M | $211M | $141M | $413M | $794M | $1.8B | $1.3B | $328M |
| Total debt | $2.2B | $2.1B | $1.9B | $1.8B | $1.8B | $1.6B | $1.7B | $1.8B | $2.1B | $1.8B |
| Finance lease liabilities | β | β | β | β | $31.5M | β | $44.8M | $49.2M | $49.5M | $55.2M |
| Current assets | $6.9B | $5.6B | $6.7B | $6.7B | $6.3B | $8.0B | $9.4B | $9.1B | $8.7B | $8.1B |
| Current liabilities | $6.5B | $5.5B | $5.9B | $5.6B | $4.9B | $6.3B | $7.0B | $5.9B | $5.4B | $5.3B |
| Inventory | $2.4B | $2.6B | $2.8B | $2.9B | $2.7B | $3.3B | $3.7B | $3.2B | $3.1B | $3.3B |
| Property and equipment, net | $5.5B | $5.4B | $5.1B | $5.1B | $5.0B | $4.8B | $4.7B | $4.9B | $5.2B | $5.5B |
| Goodwill | $144M | $138M | $138M | $172M | $172M | $172M | $180M | $180M | $180M | $239M |
| Intangible assets | $44.8M | $33.3M | $29.3M | $71.2M | $65.0M | $58.4M | $53.2M | $47.0M | $42.1M | $94.4M |
| Total assets | $17.3B | $15.8B | $16.4B | $16.4B | $16.0B | $17.6B | $18.8B | $19.0B | $18.7B | $18.9B |
| Total liabilities | $9.5B | $8.1B | $8.2B | $7.8B | $7.2B | $8.6B | $9.4B | $8.5B | $8.0B | $7.8B |
| Preferred stock | $2.2B | $2.3B | $2.3B | $2.3B | $2.3B | $2.3B | $2.3B | $2.3B | $2.3B | $2.3B |
| Shareholders' equity | $7.9B | $7.7B | $8.2B | $8.6B | $8.8B | $9.0B | $9.5B | $10.4B | $10.8B | $11.1B |
| Margins | ||||||||||
| Gross margin | 3.2% | 2.8% | 3.3% | 4.3% | 3.5% | 2.5% | 4.5% | 5.2% | 4.5% | 3.2% |
| Operating margin | 1.0% | β0.5% | 1.4% | 2.1% | 1.0% | 0.5% | 2.4% | 2.9% | 1.5% | 0.3% |
| EBITDA margin | 2.4% | 1.0% | 2.8% | 3.6% | 2.7% | 1.7% | 3.3% | 4.1% | 2.9% | 2.1% |
| Net margin | 1.3% | 0.2% | 2.4% | 2.6% | 1.5% | 1.4% | 3.5% | 4.2% | 2.8% | 1.7% |
| FCF margin | 1.9% | 1.6% | 2.2% | 2.2% | 2.4% | 1.1% | 3.3% | 6.0% | 1.2% | β0.3% |
| Net interest share of revenue | β0.2% | β | β | β | β | β | β | β | β | β |
| Returns | ||||||||||
| Return on capital | 2.9% | β1.4% | 4.7% | 6.5% | 2.7% | 2.0% | 10.1% | 12.1% | 5.0% | 0.7% |
| Return on capital employed | 2.7% | β1.7% | 4.3% | 6.1% | 2.5% | 1.8% | 9.5% | 10.3% | 4.4% | 0.7% |
| Return on equity | 4.9% | 0.9% | 9.8% | 9.9% | 4.9% | 6.2% | 18.2% | 19.1% | 10.4% | 5.5% |
| Return on assets | 2.2% | 0.4% | 4.8% | 5.1% | 2.6% | 3.3% | 9.2% | 10.1% | 5.9% | 3.2% |
| Return on tangible equity | 5.0% | 1.0% | 9.7% | 9.9% | 4.9% | 6.3% | 18.2% | 18.6% | 10.5% | 5.6% |
| Growth | ||||||||||
| Revenue growth | β | 5.5% | 2.0% | β2.4% | β11.0% | 35.4% | 24.3% | β4.6% | β13.9% | β9.7% |
| Net income growth | β | β81.3% | 983.8% | 7.0% | β49.1% | 31.1% | 203.1% | 13.2% | β42.0% | β45.8% |
| FCF growth | β | β10.1% | 40.9% | β3.1% | β4.0% | β34.2% | 261.8% | 70.8% | β82.9% | β120.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.5x | 6.4x | 1.6x | 1.4x | 2.2x | 1.7x | 0.6x | 0.1x | 0.8x | 2.0x |
| Debt / equity | 0.3x | 0.3x | 0.2x | 0.2x | 0.2x | 0.2x | 0.2x | 0.2x | 0.2x | 0.2x |
| Interest coverage | 2.6x | β1.0x | 3.0x | 3.9x | 2.4x | 2.0x | 9.9x | 9.8x | 5.6x | 0.6x |
| Current ratio | 1.1x | 1.0x | 1.1x | 1.2x | 1.3x | 1.3x | 1.3x | 1.5x | 1.6x | 1.5x |
| Quick ratio | 0.7x | 0.6x | 0.7x | 0.7x | 0.7x | 0.7x | 0.8x | 1.0x | 1.0x | 0.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.3% | 1.4% | 1.1% | 1.4% | 1.5% | 0.8% | 0.7% | 1.2% | 2.1% | 2.1% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 7.0 | 7.0 | 4.0 | 6.0 | 8.0 | 6.0 | 4.0 | 4.0 |
| Altman Z'' | 1.4 | 1.2 | 1.8 | 2.2 | 2.3 | 2.1 | 2.7 | 3.3 | 3.3 | 3.0 |
| Accruals ratio | β5.1% | β5.3% | β1.9% | β1.9% | β4.1% | β1.2% | β1.5% | β7.3% | β0.9% | β0.2% |
Source: SEC EDGAR XBRL filings (CIK 0000823277). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.